-
ATYR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
aTyr Pharma (ATYR)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 14.38 mm | 14.38 mm | 14.38 mm | 14.38 mm | 14.38 mm | 14.38 mm |
Cash burn (monthly) | (no burn) | (no burn) | 6.05 mm | 5.67 mm | 4.39 mm | 5.59 mm |
Cash used (since last report) | n/a | n/a | 32.05 mm | 30.05 mm | 23.24 mm | 29.61 mm |
Cash remaining | n/a | n/a | -17.67 mm | -15.67 mm | -8.86 mm | -15.23 mm |
Runway (months of cash) | n/a | n/a | -2.9 | -2.8 | -2.0 | -2.7 |
13F holders | Current |
---|---|
Total holders | 83 |
Opened positions | 30 |
Closed positions | 8 |
Increased positions | 24 |
Reduced positions | 12 |
13F shares | Current |
---|---|
Total value | 196.96 bn |
Total shares | 60.27 mm |
Total puts | 40.30 k |
Total calls | 51.10 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
FHI Federated Hermes | 14.67 mm | $53.09 bn |
FMR | 12.10 mm | $43.79 bn |
Point72 Asset Management | 4.88 mm | $17.68 bn |
Vanguard | 3.60 mm | $13.05 bn |
Tikvah Management | 2.46 mm | $8.91 bn |
Woodline Partners | 1.68 mm | $6.09 bn |
Alta Partners VIII | 1.59 mm | $11.04 mm |
BlackRock | 1.53 mm | $5.52 bn |
Aspire Capital Fund | 1.31 mm | $8.18 mm |
Alyeska Investment | 1.28 mm | $4.63 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Feb 25 | Denyes Nancy | Common Stock | Sell | Dispose S | No | No | 3.78 | 899 | 3.40 k | 26,555 |
4 Feb 25 | Broadfoot Jill Marie | Common Stock | Sell | Dispose S | No | No | 3.78 | 1,254 | 4.74 k | 31,763 |
3 Feb 25 | Denyes Nancy | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,687 | 0.00 | 27,454 |
3 Feb 25 | Denyes Nancy | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,687 | 0.00 | 2,687 |
3 Feb 25 | Broadfoot Jill Marie | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,750 | 0.00 | 33,017 |
3 Feb 25 | Broadfoot Jill Marie | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,750 | 0.00 | 3,750 |
3 Feb 25 | Shukla Sanjay | Common Stock | Option exercise | Acquire M | No | No | 0 | 10,375 | 0.00 | 146,923 |
3 Feb 25 | Shukla Sanjay | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 10,375 | 0.00 | 10,375 |
8 Jan 25 | Denyes Nancy | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 3.74 | 275,000 | 1.03 mm | 275,000 |
8 Jan 25 | Shukla Sanjay | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 3.74 | 1,000,000 | 3.74 mm | 1,000,000 |